AI assistant
Sending…
Chemours Co — Director's Dealing 2023
Jan 4, 2023
31561_dirs_2023-01-04_a65f4898-e603-4f13-a452-3d8a3cd4857c.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: Chemours Co (CC)
CIK: 0001627223
Period of Report: 2022-12-30
Reporting Person: Kane Erin N (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2022-12-30 | Stock Units | $ | A | 816.4598 | Acquired | Common Stock (816.4598) | Direct |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 32511.5645 | Direct |
Footnotes
F1: Includes stock units and dividend equivalent units.
F2: Units are credited under the Chemours deferred compensation plan for directors and convert one-for-one to Chemours common stock.
F3: Payable upon separation of service.
More from Chemours Co
Regulatory Filings
2026
May 27
Regulatory Filings
2026
May 6
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Mar 3